Bangkok Lab And Cosmetic Public Company (BLC) Fair Value & Analysis
Consumer Defensive · TH · Market cap 2.4B THB
Fair value as of: Jun 24, 2026
From 16 valuation models · updated 5 days ago
Share price −2.5% over the past month.
Price vs Fair Value (12 months)
12‑month range 3.48 THB – 4.70 THB · fair‑value band 3.55 THB – 6.59 THB · the 3.82 THB price screens below the 5.07 THB fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Bangkok Lab And Cosmetic Public Company (BLC) currently trades at 3.82 THB, while our model-based Fair Value estimate is 5.07 THB — implying the stock looks roughly 32.7% undervalued today. We read business quality at 94/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, Bangkok Lab And Cosmetic Public Company generated revenue of 1.7B THB at a net margin of 8.9%. Revenue declined 5.4% year over year. It earns a return on equity of 8.7%. Net debt stands at 57.5M THB. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Bangkok Lab And Cosmetic Public Company Limited manufactures and distributes pharmaceuticals and medicinal chemical products for humans and animals in Thailand, Laos, Cambodia, Hongkong, Vietnam, and internationally. It distributes food supplements, cosmeceuticals, cosmetic, and pharmaceutical products; medicine, medical supplies, tonics, and supplements for animals; and supplementary food and herbs. The company also engages in provision of management consulting and logistic services; export and distribution of cosmeceuticals; wholesale and retail of modern medicines, dietary supplements, medical cosmetics, cosmetics, home remedies, herbal products, and medical devices; and the operation of direct marketing business. Bangkok Lab And Cosmetic Public Company Limited was founded in 1992 and is based in Ratchaburi, Thailand.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Bangkok Lab And Cosmetic Public Company reported revenue of 1.7B THB in FY2025 versus 1.1B THB in FY2021, a compound +11.3%/yr. Reported net income was 173M THB in FY2025, compounding +35.3%/yr from FY2021.
Open the full interactive analysis →
Similar stocks
6 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| The Procter & Gamble Company PG | 2,590 MXN | 108.66 MXN | -96% |
| L'Oréal S.A LRLCF | $450.56 | $209.17 | -54% |
| Unilever PLC UNLYF | $59.34 | $46.11 | -22% |
| Colgate-Palmolive Company CPA | €77.58 | €35.72 | -54% |
| Hindustan Unilever Limited HINDUNILVR | ₹2,122 | ₹677.55 | -68% |
| Reckitt Benckiser Group RBGLY | $12.32 | $17.37 | +41% |
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is Bangkok Lab And Cosmetic Public Company (BLC) undervalued?
What is the fair value of BLC?
What is the quality score of BLC?
What is the revenue of Bangkok Lab And Cosmetic Public Company (BLC)?
What is the net profit margin of BLC?
Does Bangkok Lab And Cosmetic Public Company pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.